Many allergic rhinitis patients use microwave, laser, freezing, radiofrequency and other treatments in some less formal hospitals. However, are these treatments as advertised by the business to cure the disease? These treatments are medically called physical therapy. The principle is that through the physical action of cautery and freezing, the nasal mucosa is scarred, the sensitivity of the nasal mucosa is reduced, and the turbinates are made smaller, thus improving ventilation and symptoms and bringing the condition under control in a relatively short period of time. However, due to the continuous metabolism of the human nasal mucosa, it tends to recover on its own. Therefore, most patients can only obtain short-term results, and some may be longer, but they cannot be “cured”. There are also some patients who suffer from dry nasal cavity and reduced sense of smell due to excessive physical therapy, resulting in atrophic rhinitis. In order to effectively control allergic rhinitis and standardize treatment, the World Health Organization has also developed “Guidelines for the Treatment of Allergic Rhinitis”. With the introduction of new, more effective and safer medications, the use of medication is of primary importance in the treatment of allergic rhinitis, and the correct use of medication can achieve the desired therapeutic effect. There are three main categories of medications for the treatment of allergic rhinitis, namely anti-allergic drugs (oral and nasal spray antihistamines, preferred medications), hormonal drugs for topical application in the nasal cavity (first-line medications) and mast cell stabilizers (only for mild cases), of which the first two are the most important. At the same time, along with active treatment, strengthening one’s own health care: avoiding contact with allergens as much as possible, paying attention to keeping warm in winter, wearing a mask when going out, doing frequent nasal health exercises, keeping the nasal cavity clean and hygienic, etc. are also very important and effective in reducing the attacks of allergic rhinitis. Allergic rhinitis and asthma should be treated at the same time Allergic rhinitis and asthma are allergic diseases that seriously affect people’s quality of life, and they used to be considered two separate diseases, but in recent years, more and more research results have confirmed that allergic rhinitis and asthma are actually the same persistent inflammatory disease in the same airway, and there is a very close relationship between the two. Epidemiological data show that people with allergic rhinitis are three to four times more likely to develop asthma than the general population, and people with common rhinitis are twice as likely to develop asthma. Allergic rhinitis occurs in the upper respiratory tract, manifesting as sneezing, runny nose, nasal congestion and other symptoms, while asthma occurs in the lower respiratory tract, manifesting as episodes of shortness of breath, coughing, etc. In the past, the two were often treated separately, with the respiratory department in charge of treating asthma and the ENT department in charge of treating allergic rhinitis, making both of them sometimes not well controlled. Therefore, experts especially remind that allergic rhinitis and asthma must be actively intervened and treated at the same time, and even simple allergic rhinitis must be actively treated to prevent it from triggering asthma. Desensitization if necessary To treat allergic rhinitis, the first thing is to avoid contact with allergens, without which there is no allergic rhinitis patient. The next step is to carry out standardized medication, and the simplest medication from the current point of view is nasal spray hormones plus oral antihistamines. In addition, desensitization therapy (also called immunotherapy) can change the allergic rhinitis patient’s own immune system, thereby reducing allergy symptoms, and is the closest treatment to a cure for allergic rhinitis. The specific treatment is a subcutaneous injection or sublingual oral administration of a dust mite preparation, which is maintained for about two years before stopping, and the effect of the medication lasts about 15 years after stopping. Who are suitable for immunotherapy? 1.Patients who can identify a clear allergen (such as dust mite) but have no way to completely remove the allergen; 2.Patients who have been receiving long-term medication but the results are not satisfactory; 3.Patients who have concerns about long-term medication and worry about the effect on liver and kidney function.